UK-US GCP Collaboration Going Strong But Mutual Recognition Not Feasible
Health Canada Has Also Joined The Partnership
While good clinical practice inspectors in the UK and the US collaborate on matters of common interest, they say that mutual recognition is simply not possible.
You may also be interested in...
Reliance on each other’s good manufacturing practice reports should allow EU and US regulators to better focus their limited inspection resources on drug manufacturers in other countries around the world.
Clinical trial inspectors from the US and the European Union are making strides in a joint inspections pilot programme they embarked on last year to identify how good clinical practice inspections can be conducted more effectively1,2.
The UK is tightening its approach to enforcing best practices in clinical trial transparency.